Inside Information according to Article 17 MAR

Ad-hoc Announcements

Archive Ad-Hoc Announcements

September 30, 2010

Bayer to accelerate transformation to address challenging market environment and enable additional growth investments

/ MORE


June 24, 2020

Bayer announces agreements to resolve major legacy Monsanto litigation

/ MORE


?

?

No Inside Information according to Article 17 MAR / Ad-hoc Announcements?were issued in year 2019.

November 29, 2018 at 02:45 p.m. CET

Bayer to strengthen core life science businesses while significantly enhancing productivity and profitability

/ MORE


June 3, 2018 at 06:44 p.m. CEST

NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer resolves capital increase with subscription rights against cash contributions in the amount of 6.0 billion euros to finance the acquisition of Monsanto

/ MORE


April 16, 2018 at?08:10 p.m. CEST?

Temasek subscribes to capital increase and acquires approximately 3.6 percent of Bayer

/ MORE

?

?

June 30, 2017 at?09:18 a.m. CEST

Bayer expects negative earnings impact from its Brazilian Crop Science business

/ MORE


February 08, 2017 at?04:35 p.m. CET

Bayer: Phase III COMPASS study with Bayer’s Rivaroxaban in Patients with Coronary or Peripheral Artery Disease Shows Overwhelming Efficacy and Meets Primary Endpoint Early

/ MORE


?

?

November 15, 2016 at 05:48 p.m. CET

Bayer to issue mandatory convertible notes

/ MORE


September 14, 2016 at 01:17 p.m. CEST

Bayer and Monsanto to Create a Global Leader in Agriculture

/ MORE


September 6, 2016 at 00:38 a.m. CEST

Negotiations regarding Monsanto acquisition advance

/ MORE


May 23, 2016 at 07:00 a.m. CEST

Bayer Offers to Acquire Monsanto for USD 122 per Share in Cash to Create a Global Leader in Agriculture?? ?

/ MORE


February 24, 2016 at 10:58 a.m. CET

Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer AG

/ MORE

?

October 1, 2015

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

Covestro stock market listing: price range and gross proceeds adjusted

/ MORE


September 18, 2015

Bayer aligns organization with Life Science businesses?? ?

/ MORE


September 4, 2015

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

Bayer plans IPO for Covestro

/ MORE


?

?

September 18, 2014

Strategic corporate decision:
Bayer plans to focus entirely on Life Science businesses

/ MORE


September 18, 2014

Strategic corporate decision:
Bayer Board of Management plans to focus entirely on Life Science businesses

/ MORE


?

?

No Ad-hoc Announcements were issued in year 2013.

No Ad-hoc Announcements were issued in year 2012.

September 29, 2011

Phase III Study of Bayer’s Rivaroxaban in Patients with Acute Coronary Syndrome Meets Primary Efficacy Endpoint

/ MORE


September 6, 2011

Bayer AG: FDA has published documents for discussion at the Advisory Committee on the new drug application for Rivaroxaban

/ MORE


?

?